ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Chip Stocks Drive Analyst Target Upgrades

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Semiconductor and cybersecurity names are dominating the analyst calendar today, with several key target price lifts pointing to renewed confidence in tech.

MRVL leads the pack. Marvell Technology's consensus target climbed to $285.00 from $284.80, with 39 out of 44 covering analysts rating it a Buy. The $183B chip maker carries just 4.2% short interest — suggesting the Street and shorts are firmly on opposite sides.

NVDA received another target bump, with the consensus rising to $327.13. That's 57 Buy ratings versus just three Holds. Analyst enthusiasm for the AI chip leader shows no sign of cooling.

CRWD got a meaningful target lift to $231.24 from $226.57. 37 analysts back the cybersecurity giant with a Buy, compared to just one Sell. CrowdStrike's short interest sits at a low 2.4% of float.

PANW also saw its consensus target rise to $390.50. Palo Alto Networks and CrowdStrike together signal broad analyst optimism across the security sector.

One outlier: FLEX bucked the trend. The electronics manufacturer's target slipped to $158.33 from $160.50 — the only name on today's list to see a downward revision. All 10 covering analysts still rate it a Buy, but the cut signals some near-term caution on margins or demand.

RVTY rounded out notable activity, with Revvity's target edging up to $125.25, supported by a clean 12-analyst consensus Hold/Buy split.

Stocks in this article

How this article was generated

Generated
4 Sept 2026, 16:20
Prompt version
v1.0
Data sources
Analyst consensus

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.